People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Pharmaceuticals, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Secura Bio Holdings, Inc. | — | Pharmaceuticals | Series D+ | $105.0M | $3.7B | 2019 |
| Secura Bio, Inc. | — | Pharmaceuticals | Series C | $50.0M | $1.8B | 2019 |
| Vetica Labs, Inc. | — | Software / Tech | Seed | $4.6M | $136.3M | 2015 |
Juan Estruch at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Juan Estruch on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brett Lund | 2 | 3 |
| Mark Spring | 2 | 2 |
| Joseph Limber | 2 | 2 |
| Jeffrey Ferrell | 1 | 2 |
| Genevieve Hansen | 1 | 1 |
| Karin Eastham | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.